MedPath

GALENIKA, PREDSTAVITELSTVO

🇷🇺Russia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Treatment of Resistant Hypertension: Cohort Study

Completed
Conditions
Resistant Hypertension
Interventions
Drug: Add-on therapy
First Posted Date
2021-10-21
Last Posted Date
2023-02-22
Lead Sponsor
Galenika AD Beograd
Target Recruit Count
731
Registration Number
NCT05087940
Locations
🇷🇸

Clinical Center of Serbia, Belgrade, Serbia

🇷🇸

Clinical Hospital Center Zemun, Belgrade, Serbia

🇷🇸

Clinical Hospital Center Zvezdara, Belgrade, Serbia

and more 9 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.